Thread Reader
Share this page!
×
Post
Share
Email
Enter URL or ID to Unroll
×
Unroll Thread
You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649
How to get URL link on X (Twitter) App
On the Twitter thread, click on
or
icon on the bottom
Click again on
or
Share Via icon
Click on
Copy Link to Tweet
Paste it above and click "Unroll Thread"!
More info at
Twitter Help
Tim Anderson
@TimAndersonMD
General internist & researcher @PittGIM + @vaequity + @PittCP3 + @ComplexCaring | Associate Editor @JAMAInternalMed | Beeson Scholar
Subscribe
Save as PDF
May 31, 2023
•
18 tweets
•
8 min read
🚨New
#Hypertension
Paper in
@JAMAInternalMed
🚨
Time for a Thread...
Link:
jamanetwork.com/journals/jamai…
The topic of managing chronic conditions & chronic medications in the hospital is a long-term interest of our group (
prescribingwiselylab.org
)
Why?
Save as PDF
Oct 22, 2021
•
23 tweets
•
8 min read
🚨New in
@JAMANetworkOpen
🚨
We examined clinical outcomes of intensifying hospitalized older adults'
#diabetes
medications at discharge...
🧓+💉+💊+ 🏥--->🏡
Link:
ja.ma/3DYuVnI
This will be a thread... For those who just want the punchline:
Save as PDF
Sep 23, 2021
•
19 tweets
•
5 min read
🔥Hot Take🔥
Are we approaching blood pressure measurement wrong in primary care?
Maybe we need to check BP less often?
Here is my pitch...
A
#hypertension
thread that might raise your BP
Central thesis
Measurement overload contributes to clinician inertia AND patient skepticism about elevated BP diagnosis.
What if we reoriented BP measurement to be a high-quality ANNUAL screening instead of a poor-quality measure done at every single office visit?
Save as PDF
Mar 16, 2020
•
4 tweets
•
3 min read
1/4
Brief reading break from COVID tweets?
Happy to share new
#HTN
work in
@JAMAInternalMed
examining the representativeness of trials underlying 2017 BP guidelines
Takeaway:<1/3 of adults rec'd additional BP meds by guidelines meet trial eligibility
ja.ma/38R5tk5
2/4
Trials most representative of adults 50-69.
Younger adults not included in trials due to low CV risk - benefit of early intensive BP treatment remains unknown
Older adults often excluded due to comorbidities, limited life expectancy, & impaired cognition.